Correlation Between In Veritas and Griffon

Can any of the company-specific risk be diversified away by investing in both In Veritas and Griffon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining In Veritas and Griffon into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between In Veritas Medical and Griffon, you can compare the effects of market volatilities on In Veritas and Griffon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in In Veritas with a short position of Griffon. Check out your portfolio center. Please also check ongoing floating volatility patterns of In Veritas and Griffon.

Diversification Opportunities for In Veritas and Griffon

0.0

Correlation Coefficient

In Veritas  Griffon

Pay attention - limited upside

The 3 months correlation between IVME and Griffon is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding In Veritas Medical and Griffon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Griffon and In Veritas is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on In Veritas Medical are associated (or correlated) with Griffon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Griffon has no effect on the direction of In Veritas i.e., In Veritas and Griffon go up and down completely randomly.

Pair Corralation between In Veritas and Griffon

If you would invest  6,773  in Griffon on September 20, 2024 and sell it today you would earn a total of  431.00  from holding Griffon or generate 6.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

In Veritas Medical  vs.  Griffon

In Veritas Medical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days In Veritas Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, In Veritas is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Griffon

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Griffon are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain technical and fundamental indicators, Griffon may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with In Veritas and Griffon

The main advantage of trading using opposite In Veritas and Griffon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if In Veritas position performs unexpectedly, Griffon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Griffon will offset losses from the drop in Griffon's long position.

The idea behind In Veritas Medical and Griffon pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.